.

Pharmaceutical Business Intelligence

  • Find generic sources and suppliers
  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Rizatriptan benzoate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for rizatriptan benzoate?

Rizatriptan benzoate is the generic ingredient in three branded drugs marketed by Glenmark Generics, Panacea Biotec Ltd, Cipla Ltd, Sandoz, Jubilant Generics, Unichem Labs Ltd, Invagen Pharms, Apotex Inc, Macleods Pharms Ltd, Nostrum Labs Inc, Aurobindo Pharma Ltd, Teva Pharms, Merck, Alkem Labs Ltd, Mylan Pharms Inc, Natco Pharma Ltd, and Emcure Pharms Ltd, and is included in twenty-seven NDAs. There is one patent protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for rizatriptan benzoate. Twenty-eight suppliers are listed for this compound.

Summary for Generic Name: rizatriptan benzoate

Tradenames:3
Patents:1
Applicants:17
NDAs:27
Drug Master File Entries: see list22
Suppliers / Packagers: see list28
Bulk Api Vendors: see list61
Clinical Trials: see list18
Patent Applications: see list775
Therapeutic Class:Antimigraine Agents
Drug Prices:see low prices
DailyMed Link:rizatriptan benzoate at DailyMed

Pharmacology for Ingredient: rizatriptan benzoate

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd
RIZATRIPTAN BENZOATE
rizatriptan benzoate
TABLET, ORALLY DISINTEGRATING;ORAL203062-002Jul 1, 2013RXNoNo► Subscribe► Subscribe
Nostrum Labs Inc
RIZATRIPTAN BENZOATE
rizatriptan benzoate
TABLET;ORAL202047-002Dec 31, 2012RXNoNo► Subscribe► Subscribe
Emcure Pharms Ltd
RIZATRIPTAN BENZOATE
rizatriptan benzoate
TABLET;ORAL204090-002Nov 26, 2013RXNoNo► Subscribe► Subscribe
Jubilant Generics
RIZATRIPTAN BENZOATE
rizatriptan benzoate
TABLET;ORAL203252-002Dec 31, 2014RXNoNo► Subscribe► Subscribe
Apotex Inc
RIZATRIPTAN BENZOATE
rizatriptan benzoate
TABLET;ORAL202244-002Dec 31, 2012RXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: rizatriptan benzoate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck
MAXALT-MLT
rizatriptan benzoate
TABLET, ORALLY DISINTEGRATING;ORAL020865-002Jun 29, 19985,602,162*PED► Subscribe
Merck
MAXALT-MLT
rizatriptan benzoate
TABLET, ORALLY DISINTEGRATING;ORAL020865-002Jun 29, 19984,371,516► Subscribe
Merck
MAXALT
rizatriptan benzoate
TABLET;ORAL020864-001Jun 29, 19985,298,520*PED► Subscribe
Merck
MAXALT-MLT
rizatriptan benzoate
TABLET, ORALLY DISINTEGRATING;ORAL020865-001Jun 29, 19985,602,162*PED► Subscribe
Merck
MAXALT-MLT
rizatriptan benzoate
TABLET, ORALLY DISINTEGRATING;ORAL020865-002Jun 29, 19984,758,598► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc